During these busy times, it pays to stay on top of the latest profit opportunities, and today’s blog post is a great place to start.
After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Portfolio Grader recommendations for 82 big blue chips.
Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
This Week’s Ratings Changes:Top 5 Blue Chip Stocks To Own Right Now: TeleNav Inc.(TNAV)
Advisors' Opinion:- [By Ethan Ryder]
ValuEngine upgraded shares of Telenav (NASDAQ:TNAV) from a sell rating to a hold rating in a research note published on Saturday.
Several other equities research analysts also recently issued reports on TNAV. BidaskClub upgraded Telenav from a sell rating to a hold rating in a report on Friday. Zacks Investment Research upgraded Telenav from a sell rating to a hold rating in a report on Thursday, April 5th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Buy and an average target price of $11.17.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Telenav (TNAV)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:
Get Telenav alerts: Telenav, Inc. (TNAV) CEO HP Jin on Q4 2018 Results – Earnings Call Transcript (seekingalpha.com) Telenav EPS in-line, beats on revenue (seekingalpha.com) Telenav: Fiscal 4Q Earnings Snapshot (finance.yahoo.com) Telenav (TNAV) Reports Q4 Loss, Tops Revenue Estimates (finance.yahoo.com) Telenav (TNAV) Posts Earnings Results, Meets Estimates (americanbankingnews.com)TNAV has been the topic of a number of analyst reports. ValuEngine raised shares of Telenav from a “strong sell” rating to a “sell” rating in a research report on Saturday, June 2nd. B. Riley reaffirmed a “buy” rating on shares of Telenav in a research report on Monday, July 23rd. Finally, BidaskClub raised shares of Telenav from a “sell” rating to a “hold” rating in a research report on Wednesday, July 25th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and two have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $9.25.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Telenav (TNAV)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Telenav Inc (NASDAQ:TNAV) has received a consensus rating of “Buy” from the six analysts that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $11.17.
Top 5 Blue Chip Stocks To Own Right Now: PennantPark Investment Corporation(PNNT)
Advisors' Opinion:- [By Ethan Ryder]
Get a free copy of the Zacks research report on PennantPark Investment (PNNT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
BidaskClub upgraded shares of PennantPark Investment (NASDAQ:PNNT) from a sell rating to a hold rating in a research report report published on Thursday morning.
- [By Ethan Ryder]
Live Ventures (NASDAQ: LIVE) and PennantPark Investment (NASDAQ:PNNT) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.
- [By Ethan Ryder]
Shares of PennantPark Investment Corp. (NASDAQ:PNNT) have earned an average rating of “Hold” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. Five research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $8.00.
Top 5 Blue Chip Stocks To Own Right Now: Rent-A-Center Inc.(RCII)
Advisors' Opinion:- [By Logan Wallace]
OMERS ADMINISTRATION Corp decreased its holdings in shares of Rent-A-Center Inc (NASDAQ:RCII) by 52.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 72,200 shares of the company’s stock after selling 79,200 shares during the period. OMERS ADMINISTRATION Corp owned about 0.14% of Rent-A-Center worth $623,000 as of its most recent SEC filing.
- [By Shane Hupp]
Rent-A-Center Inc (NASDAQ:RCII) saw a large drop in short interest in June. As of June 15th, there was short interest totalling 21,844,410 shares, a drop of 21.9% from the May 31st total of 27,979,079 shares. Based on an average daily volume of 5,032,779 shares, the short-interest ratio is presently 4.3 days. Currently, 45.0% of the shares of the stock are short sold.
- [By Logan Wallace]
AerCap (NYSE: AER) and Rent-A-Center (NASDAQ:RCII) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, analyst recommendations and valuation.
Top 5 Blue Chip Stocks To Own Right Now: Apricus Biosciences, Inc(APRI)
Advisors' Opinion:- [By Paul Ausick]
Apricus Biosciences Inc. (NASDAQ: APRI) also dropped about 38% Monday to post a new 52-week low of $0.26. Shares closed at $0.42 on Friday and the stock’s 52-week high is $3.34. Volume was more than three times the daily average of around 1.4 million shares. The company is considering its options after the U.S. FDA directed the firm to develop a new formulation for its erectile dysfunction drug, Vitaros.
- [By William Romov]
California-based Apricus Biosciences Inc. (Nasdaq: APRI) develops treatments in the areas of urology and rheumatology. Its lead product, Vitaros, is a topically applied cream for the treatment of erectile dysfunction (ED).
- [By Alexander Bird]
Here are last week's top-performing penny stocks:
Penny Stock Current Share Price Last Week's Gain Ambow Education Holdings Ltd. (NYSE: AMBO) $5.70 77.11% Nano Dimension (Nasdaq: NNDM) $2.61 75.11% Destination Maternity Corp. (Nasdaq: DEST) $5.79 71.84% CLPS Inc. (Nasdaq: CLPS) $9.72 71.15% NII Holdings Inc. (Nasdaq: NIHD) $3.20 56.33% Viveve Medical Inc. (Nasdaq: VIVE) $3.78 51.98% Galectin Therapeutics Inc. (Nasdaq: GALT) $9.18 41.82% Apricus Biosciences Inc. (Nasdaq: APRI) $0.36 34.70% Polymet Mining Corp. (NYSE: PLM) $1.01 31.13% Xenon Pharmaceuticals Inc. (Nasdaq: XENE) $8.20 28.46%Many investors struggle with finding stocks with this sort of breakout potential because they don't know where to look.
- [By Chris Lange]
Apricus Biosciences Inc. (NASDAQ: APRI) has a PDUFA goal date for completion of the FDA's review of the Vitaros NDA set on February 17. Vitaros is a novel, on-demand topical cream for the treatment of erectile dysfunction (ED) and a new potential entrant into the U.S. ED treatment market. So far Vitaros has been approved in Canada, Mexico and certain countries in Europe, Latin America and the Middle East. Shares of Apricus were last seen at $2.22, with a 52-week range of $0.86 to $3.49 and a consensus price target of $3.50.
Top 5 Blue Chip Stocks To Own Right Now: Deckers Outdoor Corporation(DECK)
Advisors' Opinion:- [By Stephan Byrd]
Waddell & Reed Financial Inc. lessened its holdings in shares of Deckers Outdoor Corp (NYSE:DECK) by 52.2% during the second quarter, HoldingsChannel.com reports. The firm owned 55,000 shares of the textile maker’s stock after selling 60,000 shares during the quarter. Waddell & Reed Financial Inc.’s holdings in Deckers Outdoor were worth $6,209,000 at the end of the most recent quarter.
- [By Motley Fool Staff]
Deckers Outdoor (NYSE:DECK) Q4 2018 Earnings Conference CallMay. 24, 2018 4:30 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Deckers Outdoor (DECK)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
Deckers Outdoor (NYSE:DECK) received a $99.00 price objective from research analysts at Piper Jaffray Companies in a research report issued to clients and investors on Friday. The firm currently has a “hold” rating on the textile maker’s stock. Piper Jaffray Companies’ price target suggests a potential downside of 4.50% from the company’s previous close. The analysts noted that the move was a valuation call.
No comments:
Post a Comment